1
Participants
Start Date
March 22, 2023
Primary Completion Date
July 7, 2023
Study Completion Date
May 6, 2024
ReCell
"The perioral area of the face will be treated with CO2 laser. Randomization would occur before study initiation with subjects assigned either left perioral or right perioral RECELL treatment based on their subject enrollment number. The study team member who prepares and blinds the RECELL will create the list of subject ID numbers with subject ID number randomly assigned to either left perioral or right perioral treatment group. This will be completed prior to any patient enrollment in the study. Intraoperatively, RECELL and Placebo will be provided to surgeons and assistants in opaque application devices prepared by a trained, designated study team member.~Both the treatment and placebo sides, will be dressed with a standard autologous cell suspension post treatment dressing (Telfa Clear and Xeroform)."
Wake Forest University Health Sciences, Winston-Salem
Collaborators (1)
Avita Medical
INDUSTRY
Wake Forest University Health Sciences
OTHER